home / stock / crmd / crmd news

CRMD News and Press, CorMedix Inc. From 09/26/19

Stock Information
Company Name: CorMedix Inc.
Stock Symbol: CRMD
Market: NYSE
Website: cormedix.com
Menu
CRMD CRMD Quote CRMD Short CRMD News CRMD Articles CRMD Message Board
Get CRMD Alerts

News, Short Squeeze, Breakout and More Instantly...
CRMD - CorMedix Inc. to Present at the Cantor 2019 Global Healthcare Conference

BERKELEY HEIGHTS, N.J., Sept. 26, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that CorMedix m...
CRMD - CorMedix Inc. Announces Exercises of Outstanding Warrants

BERKELEY HEIGHTS, N.J., Sept. 26, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that as part of...

CRMD - CorMedix Inc. to Present at the H.C. Wainwright 21st Annual Global Investment Conference

BERKELEY HEIGHTS, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that management...

CRMD - CorMedix Inc. Announces Exchange Agreement With Its Largest Investor

BERKELEY HEIGHTS, N.J., Aug. 14, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it has ente...
CRMD - Cormedix down 4% premarket on Q2 results, Neutrolin update

Cormedix (NYSEMKT: CRMD ) Q2 results : More news on: CorMedix, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...

CRMD - CorMedix, Inc. (CRMD) CEO Khoso Baluch on Q2 2019 Results - Earnings Call Transcript

CorMedix, Inc. (CRMD) Q2 2019 Results Conference Call August 13, 2019 04:30 PM ET Company Participants Dan Ferry - MD, LifeSci Advisors Khoso Baluch - CEO Bob Cook - CFO Phoebe Mounts - EVP and General Counsel Jack Armstrong - EVP, Technical Operations Conference Call Part...

CRMD - CorMedix EPS beats by $0.18

CorMedix (NYSEMKT: CRMD ): Q2 GAAP EPS of -$0.03 beats by $0.18 . Revenue of $35.27M (+367.2% Y/Y) Press Release More news on: CorMedix, Inc., Earnings news and commentary, Healthcare stocks news, ,

CRMD - CorMedix Inc. Reports Second Quarter and Six Month 2019 Financial Results and Provides Business Update

BERKELEY HEIGHTS, N.J., Aug. 13, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced financial result...

CRMD - CorMedix Inc. to Report Second Quarter 2019 Financial Results and Provide a Corporate Update on August 13

BERKELEY HEIGHTS, N.J., Aug. 01, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will rep...

CRMD - CorMedix Presents at FDA Public Meeting on the Limited Population Pathway for Antibacterial and Antifungal Drugs

BERKELEY HEIGHTS, N.J., July 17, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,  announced today that Dr. P...
Previous 10 Next 10